L-(−)-α-Methyldopa CAS: 555-30-6
MF: C10H13NO4
MW: 211.22
A DDC inhibitor and antihypertensive.

L-(−)-α-Methyldopa (CAS 555-30-6)

L-(andminus)-α-Methyldopa | CAS 555-30-6 is rated 5.0 out of 5 by 1.
  • y_2020, m_3, d_30, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203092, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 139ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Synonym: MK-35; Baypresol; Hyperpax
Application: A DDC inhibitor and antihypertensive
CAS Number: 555-30-6
Purity: ≥98%
Molecular Weight: 211.22
Molecular Formula: C10H13NO4
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

L-(-)-α-Methyldopa is a DDC inhibitor and antihypertensive.


References

1. van Zwieten, P.A., et al. 1984. Hypertension. 6: 28-33. PMID: 6094346
2. Kapoor, V., et al. 1989. Eur. J. Pharmacol. 164: 531-538. PMID: 2767124

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in DMSO (75 mM), water, and dilute hydrochloric acid.
Storage :
Store at -20° C
Melting Point :
300° C
Boiling Point :
396.62-486.6° C at 760 mmHg (Predicted)
Density :
1.40 g/cm3 (Predicted)
Refractive Index :
n20D 1.64
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
AY5950000
PubChem CID :
38853
Merck Index :
14: 6055
EC Number :
209-089-2
SMILES :
C[[email protected]](CC1=CC(=C(C=C1)O)O)(C(=O)O)N

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

L-(−)-α-Methyldopa  Product Citations

See how others have used L-(−)-α-Methyldopa. Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 32067637  Elife. 9:

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 123ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Kapoor Kapoor, V. et al. (PubMed 2767124) observed a decrease in blood pressure following administration of L-(-)- -Methyldopa in urethane anesthetized rats. -SCBT Publication Review
Date published: 2015-06-12
  • y_2020, m_3, d_30, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203092, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 28ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.